First Time Loading...

Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932

Watchlist Manager
Wuhan Easy Diagnosis Biomedicine Co Ltd Logo
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Watchlist
Price: 19.92 CNY 0.5% Market Closed
Updated: May 18, 2024
Wuhan Easy Diagnosis Biomedicine Co Ltd
/
Income Statement
/
Cost of Revenue

Wuhan Easy Diagnosis Biomedicine Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Wuhan Easy Diagnosis Biomedicine Co Ltd
Cost of Revenue Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Cost of Revenue
-¥171.7m
CAGR 3-Years
22%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cost of Revenue
-¥486.1m
CAGR 3-Years
-51%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cost of Revenue
-¥3.8B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-15%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cost of Revenue
-¥12.6B
CAGR 3-Years
-17%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cost of Revenue
-¥2.8B
CAGR 3-Years
5%
CAGR 5-Years
-8%
CAGR 10-Years
-20%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cost of Revenue
-¥5.9B
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Cost of Revenue?
Cost of Revenue
-171.7m CNY

Based on the financial report for Mar 31, 2024, Wuhan Easy Diagnosis Biomedicine Co Ltd's Cost of Revenue amounts to -171.7m CNY.

What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-32%

Over the last year, the Cost of Revenue growth was 95%. The average annual Cost of Revenue growth rates for Wuhan Easy Diagnosis Biomedicine Co Ltd have been 22% over the past three years , -32% over the past five years .

ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.